Company News


November 6, 2001

Notice regarding Acquisition of Ono Pharmaceutical's Own Shares
At the meeting of the Board of Directors held on November 6, 2001, Ono Pharmaceutical Co., Ltd . decided to purchase its own shares as described below, pursuant to Section 1 , Article 3 of the former Special Law regarding Cancellation of Shares due to the application of Section 4 , Article 3 of the supplementary provision of the Law regarding the Partial Amendments to the Commercial Code , etc. of Japan (Law No. 79, 2001).
     1. Type of shares to be acquired : Ono Pharmaceutical's common stock
     2. Total number of shares to be acquired : 2,500,000 shares (maximum)
     3. Total acquisition value of shares : 11,000,000,000 yen (maximum)

      For reference:
     1. Ono Pharmaceutical's total number of issued shares (as of October 31, 2001): 122,919,000 shares
     2. Total number of shares that may be bought back and retired according to the Articles of Incorporation: 10,000,000 shares
Total number of shares acquired since the date appointed in the Articles of Incorporation: 0 shares

      Corporate Information
     Corporate name : Ono Pharmaceutical Co., Ltd.
     Representative : Toshio Ueno, Chairman and CEO
     Stock code : 4528
     Stock listings : First sections of Tokyo Stock Exchange and Osaka Securities Exchange
     Inquiries : Kinya Morimoto, Director, Public Relations
     Tel. : +81-6-6222-5551